Johnson Johnson Profile

USD 1.99  1.48%

Exercise or conversion by Dominic Caruso of 30000 shares of Johnson Johnson subject to Rule 16b-3

Johnson Johnson insider trading alert for exercise of common stock by Dominic Caruso, VP Finance; CFO, on August 18, 2018. This event was filed by Johnson Johnson with SEC on 2013-07-19. Statement of changes in beneficial ownership - SEC Form 4. Dominic Caruso is currently serves as cfo, vp of fin. and member of executive committee of Johnson Johnson [view details]   

Johnson Johnson Summary

Johnson & Johnson are known for their many different products. Odds are if you search your bathroom you will find multiple products made by this company. Solid and sound, the company has been upgraded by Wells Fargo, which is positive news for price movement. As well as that, the company has acquired the company Actelion, which operates in the biotech industry. [more]
Johnson Johnson (JNJ) is traded on New York Stock Exchange in USA. It is located in One Johnson & Johnson Plaza and employs 134,000 people. The company currently falls under 'Mega-Cap' category with total capitalization of 350.31 B. Johnson Johnson runs under Healthcare sector within Healthcare Products industry. This company has 2.68 B outstanding shares of which 16.69 M shares are currently shorted by investors with about 2.47 days to cover shorted positions. JOHNSON AND JOHNS has about 18.14 B in cash with 17.78 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.76.
Check Johnson Johnson Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 132.48HorizonTargetOdds Above 132.48
80.21%30 days 132.48 19.35%
Based on normal probability distribution, the odds of Johnson Johnson to move above current price in 30 days from now is about 19.35% (This Johnson Johnson probability density function shows the probability of Johnson Johnson Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares210.2 M25.5 B
Blackrock IncCommon Shares178.3 M21.6 B
View Johnson Johnson Diagnostics

Selected Johnson Johnson Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Johnson Johnson Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Johnson Johnson are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Johnson Johnson was founded in 1885 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 134000 people. more
NameJohnson Johnson
ChairmanAlex GorskyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 5 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Healthcare Products
InstrumentUSA Stock View All
RegionNorth America
Business AddressOne Johnson & Johnson Plaza
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number0000200406
IndustryHealthcare Products
Phone732 524 0400
CurrencyUSD - US Dollar


Johnson Johnson Corporate Directors
William Perez Independent Director
Mary Coleman Independent Director
Mary Beckerle Director
Please also check Risk vs Return Analysis. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.